GRISACTIN 250 (Grisactin 250 microcrystalline 250 mg)
Generic Name: griseofulvin
This pill with imprint "GRISACTIN 250" is Yellow, Capsule-shape and has been identified as Grisactin 250 microcrystalline 250 mg. It is manufactured by Wyeth-Ayerst Laboratories.
Grisactin 250 is used in the treatment of dermatophytosis; tinea corporis; tinea barbae; onychomycosis, toenail; tinea pedis (and more), and belongs to the drug class miscellaneous antifungals. Risk cannot be ruled out during pregnancy. Grisactin 250 microcrystalline 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- griseofulvin
- Imprint:
- GRISACTIN 250
- Strength:
- microcrystalline 250 mg
- Color:
- Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antifungals
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Wyeth-Ayerst Laboratories
More about Grisactin 250 (griseofulvin)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- 0 Reviews – Add your own review/rating
- Drug class: miscellaneous antifungals
Consumer resources
Other brands: Grifulvin V, Gris-PEG, Fulvicin U/F, Fulvicin P/G
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
